×
Breaking News
International Thalassaemia Day 2026 | A New Theme for Global Action
wAIHA | Sovleplenib Demonstrates Positive Phase III Clinical Results
Thalassaemia in the Americas | New TIF White Paper Calls for Coordinated Action and Equity in Care
The MENA Thalassaemia Experience: A Two-Day, In-Person Masterclass | Dubai, 24–25 April 2026
U.S. Exit from WHO | Implications for Global Health Cooperation and Preparedness
SICKLE CELL DISEASE | Alzheimer’s Drug Demonstrates Potential Therapeutic Benefit
FDA APPROVES AQVESME™ (mitapivat) | First Oral Therapy for Anaemia Across All Forms of Thalassaemia
PUTTING PATIENTS FIRST IN CLINICAL RESEARCH | New EU Recommendations to Reduce Trials Bureaucracy
EU AGREES LANDMARK REFORM OF PHARMACEUTICAL LEGISLATION | What It Means for Patients and Public Health
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
English
Italiano
العربية
English
Ελληνικά
Français
Deutsch
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Other Anaemias
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
VisibilityVoice Value
VisibilityVoice Value
News
20 hours ago
International Thalassaemia Day 2026 | A New Theme for Global Action
Read More »
Back to top button
Close
Search for
